skip to main content
US FlagAn official website of the United States government
dot gov icon
Official websites use .gov
A .gov website belongs to an official government organization in the United States.
https lock icon
Secure .gov websites use HTTPS
A lock ( lock ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.


Title: Effect of simulated body fluid formulation on orthopedic device apatite‐forming ability assessment
Abstract Integration of native bone into orthopedic devices is a key factor in long‐term implant success. The material‐tissue interface is generally accepted to consist of a hydroxyapatite layer so bioactive materials that can spontaneously generate this hydroxyapatite layer after implantation may improve patient outcomes. Per the ISO 22317:2014 standard, “Implants for surgery – In vitro evaluation for apatite‐forming ability of implant materials,” bioactivity performance statements can be assessed by soaking the material in simulated body fluid (SBF) and evaluating the surface for the formation of a hydroxyapatite layer; however, variations in test methods may alter hydroxyapatite formation and result in false‐positive assessments. The goal of this study was to identify the effect of SBF formulation on bioactivity assessment. Bioglass® (45S5 and S53P4) and non‐bioactive Ti‐6Al‐4V were exposed to SBF formulations varying in calcium ion and phosphate concentrations as well as supporting ion concentrations. Scanning electron microscopy and X‐ray powder diffraction evaluation of the resulting hydroxyapatite layers revealed that SBF enriched with double or quadruple the calcium and phosphate ion concentrations increased hydroxyapatite crystal size and quantity compared to the standard formulation and can induce hydroxyapatite crystallization on surfaces traditionally considered non‐bioactive. Altering concentrations of other ions, for example, bicarbonate, changed hydroxyapatite induction time, quantity, and morphology. For studies evaluating the apatite‐forming ability of a material to support bioactivity performance statements, test method parameters must be adequately described and controlled. It is unclear if apatite formation after exposure to any of the SBF formulations is representative of an in vivo biological response. The ISO 23317 standard test method should be further developed to provide additional guidance on apatite characterization and interpretation of the results.  more » « less
Award ID(s):
2037636
PAR ID:
10400062
Author(s) / Creator(s):
 ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  
Publisher / Repository:
Wiley Blackwell (John Wiley & Sons)
Date Published:
Journal Name:
Journal of Biomedical Materials Research Part B: Applied Biomaterials
Volume:
111
Issue:
5
ISSN:
1552-4973
Page Range / eLocation ID:
p. 987-995
Format(s):
Medium: X
Sponsoring Org:
National Science Foundation
More Like this
  1. We present a luminescence study investigating the dissolution of rare-earth-doped hydroxyapatite scaffolds in simulated body fluid (SBF), aiming to assess the luminescence stability of Tb-, Ce-, and Eu-doped scaffolds over time. Our findings reveal a consistent decrease in luminescence emission intensity across all samples over a four-week period in which the scaffolds were immersed in the SBF. In addition, energy-dispersive spectroscopy confirms a decrease in rare-earth ion concentration in the scaffolds with respect to time, whereas fluorescence spectroscopy shows the presence of rare-earth ions in the SBF, indicating the partial dissolution of the scaffolds over time. The use of rare-earth ions as luminescence markers provides insights into the mechanisms of apatite formation in hydroxyapatites. Thus, these scaffolds may find wider use in regenerative medicine, particularly in targeted drug delivery systems, where their luminescent properties have the potential to noninvasively track drug release. 
    more » « less
  2. null (Ed.)
    To treat impairments in hard tissues or overcome pathological calcification in soft tissues, a detailed understanding of mineralization pathways of calcium phosphate materials is needed. Here, we report a detailed mechanistic study of hydroxyapatite (HA) mineralization pathways in an artificial saliva solution via in situ liquid cell transmission electron microscopy (TEM). It is found that the mineralization of HA starts by forming ion-rich and ion-poor solutions in the saliva solution, followed by coexistence of the classical and nonclassical nucleation processes. For the nonclassical path, amorphous calcium phosphate (ACP) functions as the substrate for HA nucleation on the ACP surface, while the classical path features direct HA nucleation from the solution. The growth of HA crystals on the surface of ACP is accompanied by the ACP dissolution process. The discoveries reported in this work are important to understand the physiological and pathological formation of HA minerals, as well as to engineer the biomineralization process for bone healing and hard tissue repairs. 
    more » « less
  3. Magnesium (Mg) alloys are being investigated as a biodegradable metallic biomaterial because of their mechanical property profile, which is similar to the human bone. However, implants based on Mg alloys are corroded quickly in the body before the bone fracture is fully healed. Therefore, we aimed to reduce the corrosion rate of Mg using a double protective layer. We used a magnesium-aluminum-zinc alloy (AZ91) and treated its surface with micro-arc oxidation (MAO) technique to first form an intermediate layer. Next, a bioceramic nanocomposite composed of diopside, bredigite, and fluoridated hydroxyapatite (FHA) was coated on the surface of MAO treated AZ91 using the electrophoretic deposition (EPD) technique. Our in vivo results showed a significant enhancement in the bioactivity of the nanocomposite coated AZ91 implant compared to the uncoated control implant. Implantation of the uncoated AZ91 caused a significant release of hydrogen bubbles around the implant, which was reduced when the nanocomposite coated implants were used. Using histology, this reduction in the corrosion rate of the coated implants resulted in an improved new bone formation and reduced inflammation in the interface of the implants and the surrounding tissue. Hence, our strategy using a MAO/EPD of a bioceramic nanocomposite coating (i.e., diopside-bredigite-FHA) can significantly reduce the corrosion rate and improve the bioactivity of the biodegradable AZ91 Mg implant. 
    more » « less
  4. The development of algal biorefineries is strongly associated with the nutrient management, particularly phosphorus, which is a limited mineral resource. Flash hydrolysis (FH) has been widely applied to a variety of algae species to fractionate its constituents. This chemical-free, subcritical water technique was used to extract more than 80 wt % of phosphorus available in the Scenedesmus sp. as water-soluble phosphates in the aqueous phase (hydrolysate). The phosphate-rich hydrolysate was subjected to the hydrothermal mineralization (HTM) process at 280 °C and 5–90 min of residence time to mineralize phosphates as allotropes of calcium phosphate such as hydroxyapatite (HAp) and whitlockite (WH). In the current study, the effect of reaction time on phosphate mineralization from the hydrolysate as well as the composition, structure and the morphology of the precipitates were studied. Calcium hydroxide and commercial HAp were used as the mineralizer and seeding material, respectively. More than 97 wt % of phosphate and almost 94 wt % of calcium were removed in the first 5 min of the HTM process. Results revealed that as the HTM reaction time increased, calcium phosphate precipitates transformed from WH to carbonated HAp. The integration of the proposed mineralization process with FH can be a cost-effective pathway to produce sustainable, and high value phosphate-based bioproducts from algae. The application of HAp includes biomedical applications such as synthetic bone and implant filling, drug delivery, chromatography, corrosion resistance materials, catalytic activities and fertilizers. 
    more » « less
  5. null (Ed.)
    Recent advances in the processing of wear-resistant calcium-phosphate reinforced CoCrMo composites for articulating surface applications has necessitated further investigation of performance in biological conditions relevant to patient applications. To this end, CoCrMo composites containing calcium phosphate in the form of hydroxyapatite (HA) were manufactured to study the influence of the reinforcing phase on the tribofilm formation in biologically-relevant conditions. The CoCrMo-HA composites were processed using a laser engineered net shaping (LENS™) additive manufacturing (AM) system with three distinctive compositions: CoCrMo-0%HA, CoCrMo-1%HA, and CoCrMo-3%HA. Extensive wear testing of the CoCrMo-HA composites was carried out in DMEM (cell media) and DMEM + Hyaluronic acid (found naturally in synovial fluid). Wear tests were performed at loads ranging from 5N to 20N, and wear media was measured post-test using ICP-MS techniques for the release of Co and Cr ions. During testing, all coefficients of friction remained in the 0.15-0.25 range, which was lower than the previously reported 0.50-0.75 range in DI water, indicating that the DMEM + hyaluronic acid media plays a significant role in reducing frictional contact. At loads higher than 15N, the HA-tribofilm exhibited a breakdown resulting in higher wear rates but still lower overall ion release in comparison to the CoCrMo control composition. Our results indicate that CoCrMo alloys with HA addition can significantly reduce wear rates and ion release even in the presence of naturally-occurring synovial-fluid friction-reducing constituents. 
    more » « less